SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-04-002586
Filing Date
2004-07-01
Accepted
2004-07-01 10:16:49
Documents
4
Period of Report
2004-07-01
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS INC. w98792e8vk.htm 8-K 10469
2 UNDERWRITING AGREEMENT w98792exv1w1.htm EX-1.1 186845
3 OPINION OF HOGAN & HARTSON LLP w98792exv5w1.htm EX-5.1 7388
4 PRESS RELEASE DATED JULY 1, 2004 w98792exv99w1.htm EX-99.1 3802
  Complete submission text file 0000950133-04-002586.txt   210372
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23736 | Film No.: 04893227
SIC: 2834 Pharmaceutical Preparations